#Magnesium iv anti stroke trial
This trial will also demonstrate that paramedics can safely, effectively, and rapidly start neuroprotective therapies for stroke. This study will analyze magnesium sulfate, an experimental therapy for stroke, versus placebo among ambulance-transported patients with acute stroke. Because of these potential interactions, it’s important to consult with your doctor before using magnesium oil for stroke recovery. If you’re on antibiotics, magnesium supplementation can interfere. The purpose of this multi-center, randomized, double-blind trial is to demonstrate that paramedic initiation of the neuroprotective agent magnesium sulfate in the field is an effective and safe treatment for acute stroke. Magnesium can increase the side effects of muscle relaxants, which are sometimes used for spasticity in stroke patients. It is usually given by either the intramuscular or intravenous routes. NAD is involved in hundreds of metabolic processes in the body. Magnesium is required for energy production, oxidative phosphorylation, and glycolysis. Magnesium sulfate (MgSO4) is the agent most commonly used for treatment of eclampsia and prophylaxis of eclampsia in patients with severe pre-eclampsia. NAD+ Drip NAD+, or nicotinamide adenine dinucleotide, is a critical coenzyme found in every cell of the human body. If you take more magnesium than calcium, then you are going to upset your calcium balance. There is the balance of calcium to magnesium to be kept in the range of 1:1 to 2:1. In addition, rt-PA cannot be given in the field because it is contraindicated for treatment of patients with brain hemorrhage. Magnesium is a cofactor in more than 300 enzyme systems that regulate diverse biochemical reactions in the body, including protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation 1-3. In reality, problems with magnesium supplementation usually occur when the magnesium in the IV is given too rapidly or in too high of a dose, or both.
#Magnesium iv anti stroke Activator
Each year, more than 750,000 Americans suffer a symptomatic stroke.Ĭurrently, tissue plasminogen activator (rt-PA) is the only approved treatment for acute ischemic stroke however, its usefulness is limited because most patients cannot reach medical attention within the necessary 3-hour time window. More research is needed on magnesium as an adjunct treatment in epilepsy, and to further clarify its role in Alzheimer’s and Parkinson’s. Stroke is the third leading cause of death and the leading cause of adult disability in the United States. There is strong data to suggest a role for magnesium in migraine and depression, and emerging data to suggest a protective effect of magnesium for chronic pain, anxiety, and stroke. Why Should I Register and Submit Results?.